Truncated Trk receptor isoforms lacking the kinase domain are abundantly expressed during development and in the adult; however, their function and signaling capacity is largely unknown. Interestingly, the cytoplasmic tail of the neurotrophin-3 (NT3) truncated TrkCT1- receptor is highly conserved among species, suggesting the potential for important functions in vivo. We have recently shown that NT3 interaction with TrkCT1 activates Arf6-Rac1 signaling through the scaffold protein Tamalin. We found that TrkCT1 binds also the Tamalin homolog Cybr, a scaffold protein highly expressed in the immune system. NT3 treatment of the EL4 lymphoma cell line that express endogenously both TrkCT1 and Cybr, induces intracellular re-localization of Cybr. Since Cybr is involved in pro-inflammatory cytokine-modulated cell migration, our results suggest that TrkCT1 may modulate the recruitment and migration of specific leukocyte cell populations. Indeed, in mouse in which we have deleted Cybr we find specific deficits in blood circulating leukocytes and lymphocytes present in the lymph nodes. Moreover, in a Th1-polarized-mouse model, lymphocyte trafficking is impaired by loss of Cybr and Cybr-deficient mice with aseptic peritonitis have fewer cells than controls present in the peritoneal cavity and fewer leukocytes leaving the blood stream. Mutant mice injected with Moloney-murine sarcoma/leukemia virus develop significantly larger tumors than wild type mice and have reduced lymph node enlargement suggesting reduced cytotoxic T lymphocytes migration. Taken together, these data support a role for Cybr in leukocyte trafficking, especially in response to pro-inflammatory cytokines in stress conditions. We are now investigating which of these Cybr functions are affected by NT-3/TrkC.T1. In a separate project we have investigated whether Trk Receptors are expressed in astrocytomas and peripheral nerve sheet tumor (PNST) that develop from a mouse model lacking the neurofibromatosis type 1 and p53 gene. We found that Truncated TrkB (TrkB.T1), a receptor for the neurotrophin brain derived neurotrophin factor (BDNF) is expressed in all PNST examined. We are now trying to identify the function of this receptor isoform in this type of tumors and investigate whether targeting of TrkB.T1affects tumor survival/growth.
| Arévalo, Juan Carlos; Wu, Synphen H; Takahashi, Takuya et al. (2010) The ARMS/Kidins220 scaffold protein modulates synaptic transmission. Mol Cell Neurosci 45:92-100 |
| Ahmed, Farid; Tessarollo, Lino; Thiele, Carol et al. (2008) Brain-derived neurotrophic factor modulates expression of chemokine receptors in the brain. Brain Res 1227:1-11 |
| Rivera, Juan; Tessarollo, Lino (2008) Genetic background and the dilemma of translating mouse studies to humans. Immunity 28:1-4 |
| Zeng, Hongkui; Horie, Kyoji; Madisen, Linda et al. (2008) An inducible and reversible mouse genetic rescue system. PLoS Genet 4:e1000069 |
| Coppola, Vincenzo; Barrick, Colleen A; Bobisse, Sara et al. (2006) The scaffold protein Cybr is required for cytokine-modulated trafficking of leukocytes in vivo. Mol Cell Biol 26:5249-58 |
| Esteban, Pedro F; Yoon, Hye-Young; Becker, Jodi et al. (2006) A kinase-deficient TrkC receptor isoform activates Arf6-Rac1 signaling through the scaffold protein tamalin. J Cell Biol 173:291-9 |
| Coppola, Vincenzo; Barrick, Colleen A; Southon, Eileen A et al. (2004) Ablation of TrkA function in the immune system causes B cell abnormalities. Development 131:5185-95 |
| Youn, Y H; Feng, J; Tessarollo, L et al. (2003) Neural crest stem cell and cardiac endothelium defects in the TrkC null mouse. Mol Cell Neurosci 24:160-70 |
